Comparative Pharmacology
Head-to-head clinical analysis: SYMBYAX versus ZYBAN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: SYMBYAX versus ZYBAN.
SYMBYAX vs ZYBAN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Symbyax is a combination of olanzapine (an atypical antipsychotic) and fluoxetine (a selective serotonin reuptake inhibitor). Olanzapine antagonizes dopamine D2, serotonin 5-HT2A, and other CNS receptors; fluoxetine inhibits serotonin reuptake. Synergy targets depressive and manic symptoms via dopaminergic and serotonergic modulation.
Bupropion is a selective dopamine and norepinephrine reuptake inhibitor with weak inhibition of serotonin reuptake. Its mechanism in smoking cessation and depression is not fully understood.
6 mg/25 mg to 12 mg/50 mg orally once daily; maximum 12 mg/50 mg per day.
150 mg orally once daily for 3 days, then increase to 150 mg twice daily for a total treatment duration of 7-12 weeks.
None Documented
None Documented
Olanzapine: 21-54 h (mean 30 h in adults; longer in elderly and hepatic impairment). Fluoxetine: 4-6 days (norfluoxetine 4-16 days). Extensive accumulation with chronic dosing; steady-state reached in 2-4 weeks for fluoxetine.
The terminal elimination half-life of bupropion is approximately 21 hours (range 18-24 h), while its active metabolites have longer half-lives: hydroxybupropion ~20 h, threohydrobupropion ~37 h, erythrohydrobupropion ~33 h. Steady state is achieved within 8 days.
Olanzapine: ~57% renal (7% unchanged, rest as metabolites; 30% fecal as metabolites from biliary excretion). Fluoxetine: ~60% renal (primarily as metabolites; <10% unchanged) and ~40% fecal (via biliary excretion of metabolites).
Renal excretion accounts for approximately 87% of an oral dose, with 42% as unchanged bupropion and its active metabolites (hydroxybupropion, threohydrobupropion, erythrohydrobupropion). Fecal excretion is minimal at <10%.
Category C
Category C
Antidepressant/Antipsychotic Combination
Antidepressant, Smoking Cessation Aid